TP53 haplotypes and susceptibility to breast cancer.

被引：0
|
作者：
Kristensen, Vessela
Garcia-Closas, Montserrat
Langerod, Anita
Qi, Ying
Yeager, Meredith
Burdett, Laurie
Welch, Robert
Lissowska, Jolanta
Peplonska, Beata
Bardin-Mikolajczak, Alicija
Brinton, Louise
Gerhard, Daniela S.
Perou, Charles
Borresen-Dale, Anne-Lise
Chanock, Stephen
机构：
[1] Univ Oslo, Inst Canc Res, Dept Genet, Oslo, Norway
[2] Norwegian Radium Hosp, Oslo, Norway
[3] NCI, DCEG, Bethesda, MD 20892 USA
[4] NCI, Core Genotyping Facil, ATC, Bethesda, MD 20892 USA
[5] Canc Ctr, Warsaw, Poland
[6] M Sklodowska Curie Inst Oncol, Warsaw, Poland
[7] Nofer Inst Occupat Med, Lodz, Poland
[8] NCI, OCG, Bethesda, MD 20892 USA
[9] UNC, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[10] NCI, POB, CCR, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5388
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
    A Langerød
    TI Andersen
    I Bukholm
    A-L Børresen Dale
    [J]. Breast Cancer Research, 2 (Suppl 1)
  • [2] TP53 and breast cancer
    Borresen-Dale, AL
    [J]. HUMAN MUTATION, 2003, 21 (03) : 292 - 300
  • [3] Cigarette smoking and TP53 mutations in bladder cancer.
    Zhang, ZF
    Lu, ML
    Cordon-Cardo, C
    Shu, XM
    Cao, PQ
    Connolly-Jenks, C
    Dalbagni, G
    Reuter, VE
    Scher, H
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1999, 149 (11) : S66 - S66
  • [4] TP53 Mutations in Breast and Ovarian Cancer
    Silwal-Pandit, Laxmi
    Langerod, Anita
    Borresen-Dale, Anne-Lise
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (01):
  • [5] Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
    Li, Xuerui
    Chen, Xiaoqing
    Wen, Lingzhu
    Wang, Yulei
    Chen, Bo
    Xue, Yunlian
    Guo, Liping
    Liao, Ning
    [J]. THORACIC CANCER, 2020, 11 (07) : 1861 - 1868
  • [6] TP53 variants and susceptibility to ovarian cancer in poland
    Garcia-Closas, Montserrat
    Burdett, Laurie
    Brinton, Louise
    Lissowska, Jolanta
    Sherman, Mark
    Yeager, Meredith
    Szeszenia-Dabrowska, Neonila
    Peplonska, Beata
    Welch, Robert
    Mikolajczak, Alicja Bardin
    Zatonski, Witold
    Qi, Ying
    Chanock, Stephen
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [7] The combination of immunohistochemistry for predicting TP53 mutation is useful prognostic marker in breast cancer.
    Watanabe, G.
    Ishida, T.
    Takahasi, S.
    Ishioka, C.
    Watanabe, M.
    Ohuchi, N.
    [J]. CANCER RESEARCH, 2012, 72
  • [8] The OGG1 and TP53 polymorphisms and susceptibility to breast cancer in Northwestern Iran
    Yegani, Behnaz Yaghoubpour
    Pouladi, Nasser
    [J]. HUMAN GENE, 2023, 37
  • [9] CIGARETTE SMOKING AND TP53 GENE MUTATIONS IN BLADDER CANCER.
    Samanic, C.
    Baris, D. R.
    Silverman, D. T.
    Platz, E. A.
    Strickland, P. T.
    Schwenn, M. R.
    Schned, A. T.
    Johnson, A. R.
    Kida, M.
    Jones, M. A.
    Nickerson, M. L.
    Rothman, N.
    Moore, L. E.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S4 - S4
  • [10] THE ROLE OF TP53 IN BREAST-CANCER DEVELOPMENT
    EELES, RA
    BARTKOVA, J
    LANE, DP
    BARTEK, J
    [J]. CANCER SURVEYS, 1993, 18 : 57 - 75
12345